Rare nursing home sessions on grief, isolation seek solutions for patients, staff … Cancer screening rates did not recover in 2022; ongoing drops coincide with COVID surges … Memory problems more likely...
Deaths underscore need for staffing, training to manage resident aggression
By
Jessica R. Towhey
Feb 03, 2023
The recent deaths of two nursing home residents who died after attacks by fellow residents in separate incidents has amplified providers’ focus on operating as safely as possible with often unpredictable...
Clinical briefs for Monday, Jan. 30
By
Alicia Lasek
Jan 30, 2023
With antibody treatments null, CDC advises vulnerable patients on COVID prevention, treatment … Healthy lifestyle lowers memory decline, even for those with genetic risk … Fewer in U.S. are reporting...
Can you live with 26 minutes of daily engagement?
By
Charles de Vilmorin
Jan 25, 2023
After facing more than two years of intense challenges, the senior living industry seems to be settling, and positive trends started to emerge throughout 2022.
A quarter century of improving the health and quality of life of older adults
By
Susan Hickman, Ph.D.
Jan 23, 2023
The Indiana University Center for Aging Research at Regenstrief Institute, an international leader focused on improving the health and quality of life of older adults, is commemorating its 25th anniversary.
Let’s remember MLK and his message about healthcare disparities
By
Neville M. Bilimoria
Jan 19, 2023
In this day and age of all that is going on with nursing homes, it is important to focus on areas that don’t get much attention right now, but that are, nonetheless, critically important in our society. ...
Skilled nursing deals led record year for seniors housing and care
By
Kimberly Marselas
Jan 12, 2023
The number of publicly announced seniors housing and care acquisitions rose to 527 in 2022, and skilled nursing powerhouse pacts sent the average amounts soaring.
Final day! 2023 Women of Distinction entries due by midnight tonight
By
James M. Berklan
Jan 10, 2023
Nominations for the 2023 McKnight’s Women of Distinction awards program are due by midnight ET today.
FDA approves new drug Leqembi to treat early Alzheimer’s disease
By
Alicia Lasek
Jan 09, 2023
The newly approved drug Leqembi (lecanemab) may slow progression of cognitive decline due to Alzheimer’s disease, trial data show. CMS says it may rethink Medicare coverage of drugs in Leqembi’s...
BREAKING: FDA approves new experimental drug to treat early Alzheimer’s
By
Alicia Lasek
Jan 06, 2023
The Food and Drug Administration has approved the experimental Alzheimer’s drug Leqembi (lecanemab-irmb) for clinical use in patients with early disease.